JPJAPANESE
ENENGLISH

H.U. Group
- Top Message
- The H.U. Group at a Glance
- Corporate Information
  Corporate Profile
  
  Directors & Officers
  
  History
  
  Corporate Governance
  
  H.U. Group Code of Conduct
  
  H.U. GROUP CORPORATE PROFILE
Our Business
- Efforts by the H.U. Group
Sustainability
- Sustainability Subcommittee
  Environment and Energy
  
  Human Capital
  
  Supply Chain Management
  
  Philanthropy
  
  BCP
H.U. Group
Our Business
Sustainability
News
H.U. Bioness Complex
Investor Relations
Contact Us

Investor Relations
Contact Us

Top Message
The H.U. Group at a Glance
Corporate Information
Group Brand
Group Philosophy
Group Companies

LTS : Lab Testing and its related Services
IVD : In-Vitro Diagnostics
HS : Healthcare-related Services
R&D : Research and Development
- ∟ Intellectual property
The Mission of H.U. Group
under the COVID-19 Pandemic.
- ∟ For general public
- ∟ For healthcare professionals
Efforts by the H.U. Group
- ∟ Forums, Seminars, and Exhibitions

Top Message
Sustainability at the H.U. Group
Materiality
Communication with Stakeholders
United Nations Global Compact
Sustainability Subcommittee
Reports Archive
GRI Standards Content Index
ESG Performance Data
External Ratings

Investor Relations

Management Policy
- ∟ IR Policy
- ∟ Business Risks
Medium-term Plan
Financial Highlights
IR Library
Stock & Shareholder Information
IR Calendar

TOP
Investor Relations

Investor Relations

Management Policy
- Risk Information
- IR Policy
Medium-term Plan
Financial Highlights

IR Library
IR Calendar

Stock & Shareholder Information

Latest IR News

View all

Latest IR Materials

Consolidated Financial Results for the Nine Months Ended December 31, 2022
Presentation: Financial Results for The Third Quarter of FY2022

Download

Site Map
Personal Information Protection Policy
Terms of Use
Contact Us

JPJAPANESE
ENENGLISH

Copyright © 2022 H.U. Group Holdings, Inc. All rights reserved.